Evidence map›Paper›PMID 38285160›Full record

ArticleActa neurologica Belgica2024

Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia.

Hongmin Wang, Xin Zhang, Peizhi Wang, Guining Dai, Li Liu, Yanfang Xu, Huijun Wang, Yongqian Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongmin Wang *Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Xin Zhang *Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Peizhi WangDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Guining DaiDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Li LiuDepartment of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Yanfang XuDepartment of Hepatology, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Huijun WangNeurological Function Examination Center, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.
Yongqian ZhangDepartment of Oncology, The First Hospital of Hebei Medical University, No. 89 of Donggang Road, Yuhua District, Shijiazhuang, 050031, Hebei, China. 58602170@hebmu.edu.cn.ORCID http://orcid.org/0009-0001-7386-2109

Funding

Hebei Medical Science Research Key Project 20180230
6 · The paper itself

Abstract

objectiveTo investigate the effects of electronic biofeedback combined with nursing intervention and conventional drug treatment on cognitive function in patients with vascular cognitive impairment-no dementia (VCIND).

methodsA total of 102 patients with VCIND treated in the Department of Neurology from January 2021 to May 2022 were enrolled and divided into the routine treatment group and biofeedback group according to different treatment methods. The routine treatment group was given conventional drug therapy and nursing intervention; for the biofeedback group, electronic biofeedback therapy was added, based on the routine treatment group. The Montreal Cognitive Assessment, (MoCA), Alzheimer's Disease Assessment Scale-Cognitive Subscale, (ADAS-cog), and Hamilton Depression Scale (HAMD) were checked before treatment, 2 weeks after treatment, and 3 months after treatment.

resultsAt 3 months of treatment, the scores of the MoCA and ADAS-cog scales in the biofeedback group were better than those in the routine treatment group, while no difference was detected in the HAMD scores before and after treatment and between the two groups.

conclusionElectronic biofeedback therapy for VCIND can significantly improve the MoCA score, reduce the ADAS-cog score and improve the cognitive level of patients and can be used as a complementary treatment for VCIND.

Indexed as

Biofeedback, PsychologyCognitive DysfunctionAgedFemaleHumansMaleMiddle AgedTreatment OutcomeDepressionDrug therapyElectronic biofeedbackImprovementNursing interventionVascular cognitive impairment-no dementia

Identifiers

PMID38285160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.